08.11.2023 - Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its fourth quarter and fiscal year ended September 30, 2023, and introduced .
Not the Time for the United States To Rejoin UNESCO heritage.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from heritage.org Daily Mail and Mail on Sunday newspapers.
Note: This document is a translation of a part of the original Japanese version and provided for reference purposes only. In the event of any discrepancy between the. -Today at 05:20 am- MarketScreener
EDEN PRAIRIE, Minn. (BUSINESS WIRE) Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported financial results for its third quarter ended June 30, 2023, and updated its financial guidance for its fiscal year ending Septemb.